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Abstract: Saturation transfer difference (STD) NMR spectros-
copy is extensively used to obtain epitopemaps of ligands binding
to protein receptors, thereby revealing structural details of the
interaction, which is key to direct lead optimization efforts in
drug discovery. However, it does not give information about the
nature of the amino acids surrounding the ligand in the binding
pocket. Herein, we report the development of the novel method
differential epitope mapping by STDNMR (DEEP-STDNMR)
for identifying the type of protein residues contacting the ligand.
Themethod produces differential epitopemaps through 1) differ-
ential frequency STD NMR and/or 2) differential solvent (D2O/
H2O) STD NMR experiments. The two approaches provide
different complementary information on the binding pocket. We
demonstrate that DEEP-STD NMR can be used to readily
obtain pharmacophore information on the protein. Furthermore,
if the 3D structure of the protein is known, this information also
helps in orienting the ligand in the binding pocket.
Saturation transfer difference (STD) NMR spectroscopy is
a powerful NMR technique for ligand screening and gaining
quantitative structural information from biologically relevant
protein–ligand complexes.[1] The approach is appropriate for
small-molecule binders of medium-weak affinity (high nm to
low mm), there is no upper limit for protein size,[2] and
labelling is not required. The technique is highly versatile and
popular in the context of hit identification in drug discovery.[3]
STD NMR is based on the generation of saturation on
a selected group of protein protons through selective
“saturating” irradiation. For large proteins, spin diffusion
spreads the saturation over the entire macromolecule,
ultimately leading to intermolecular NOEs with protons of
the ligand in the binding pocket. Mapping the STD NMR
intensities on the ligand structure allows identification of “all”
the ligand contacts with the protein in the complex (group
epitope mapping).[1b] However, it fails to provide information
about the ligand location/orientation in the bound state. For
this, competitive STD NMR experiments with “spy” ligands
of known binding location must be carried out.[4]
Importantly, spin diffusion does not always ensure homo-
geneous saturation over the receptor, and differences in
ligand epitope maps can be observed if STDs are acquired at
different saturating frequencies.[5,6] This is prominent in the
case of nucleic acids, where these differences are exploited to
distinguish between major- and minor-groove binders.[6] For
proteins, no methods have been described to exploit these
differences to gain additional structural information.
Although for proteins, these differences are typically small,
they can be magnified and mapped into the ligand. Notably,
ligand protons close to directly irradiated protein protons will
show a relative increase in STDs compared to conditions
where they are not directly irradiated (Figure 1a). Since the
frequencies of irradiation can be chosen, we can select what
types of protein protons will be “directly irradiated”, so that
the differences will highlight parts of the ligand contacting
those types of protein residues in the bound state (Figure 1a).
Another source of minor differences in epitope maps is the
solvent. InD2O, the polar side chains in the binding pocket have
their exchangeable protons replaced by 2H, which is inefficient
for transferring saturation.[7] In H2O, these protons can
contribute to an additional transfer of saturation compared to
D2O.
[8] This process depends on their exchange rate with bulk
water, with slowly exchanging polar protons being expected to
produce the largest variations.[8] Therefore, ligand protons
contacting these polar residues will show a relative increase in
STDs compared to the binding epitopes in D2O (Figure 1b).
In this work, we proposed to exploit these epitope
differences to get information on the types of protein protons
(aromatic, polar, or apolar) the ligand is contacting, thereby
allowing assessment of the pharmacophore of the protein. To
detect and quantify these differences, we have designed
a simple method consisting of running pairs of STD NMR
experiments under two experimental conditions (Figure 1)
and quantifying the differences in relative STDs. Each pair
consists of experiment-1 (exp1) and experiment-2 (exp2),
performed under two conditions, that is, two different
frequencies or two different solvents (D2O or H2O). The
result provides a “Differential Epitope Map” of the ligand,
which is a map of epitope differences from each pair of STD
NMR experiments. We call the method differential epitope
mapping STD NMR spectroscopy (DEEP-STD NMR).
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The differential epitope map of a ligand under two
experimental conditions (exp1 and exp2) is determined by the












To obtain a consistent scale of DSTDi factors, exp1 must
be the experiment showing larger total ligand saturation. The
term 1=nð ÞPni STD exp1; i=STD exp2; iE CE C accounts for intrinsic
differences in saturation levels under different conditions.
Ligand protons not affected by the changes in experimental
conditions should show low DSTDi factors, ideally close to 0.
The differential epitope map of the ligand is obtained by
mapping the DSTDs onto its structure. Notably, since DSTDs
reflect contacts to specific types of amino acids, if the 3D
structure of the protein is known, the method can also reveal
the orientation of the ligand in the binding pocket.
As a proof of principle, we studied two biologically
relevant protein–ligand complexes for which high-resolution
X-ray structures are available: 1) 2,7-anhydro-Neu5Ac with
RgNanH-GH33, the catalytic domain (belonging to glycoside
family GH33) of the intramolecular trans-sialidase from
human the gut symbiont Ruminococcus gnavus,[9] and 2) 3-
nitrophenyl-a-d-galactopyranoside (3NPG) with Cholera
toxin subunit B (CTB).[10] Understanding the binding of 2,7-
anhydro-Neu5Ac by sialidases is important to unveil mech-
anisms of gut microbiota adaptation.[9, 11] 3NPG is a well-
known inhibitor of CTB and is frequently chosen as
a reference for the design of novel inhibitors.
We first tested the method by analyzing the effect of
different irradiation frequencies on the binding of 2,7-
anhydro-Neu5Ac to RgNanH-GH33. For DEEP-STD
NMR, the selection of frequencies to irradiate different
types of protein protons can be based on the spectral
properties of the protein (if chemical shifts are assigned),
NMR databases (e.g., BMRB[12]), or predictions using a 3D
model of the protein.[13] We ran two STD NMR experiments
irradiating (0.5 s) at 0.60 ppm (exp1) and 6.55 ppm (exp2).
These frequencies are known to be centered in the aliphatic
and aromatic protein spectral regions, respectively.[12]
Several DSTD factors were observed (Figure 2a), con-
firming changes in the ligand binding epitope map under the
two different irradiations. The DSTD factors (0.60/6.55 ppm)
are shown in Figure 2a.
Positive DSTD factors report relative STD increases with
irradiation at 0.60 ppm (aliphatic residues), whereas negative
Figure 2. Differential Epitope Mapping (0.6/6.55 ppm) of 2,7-anhydro-
Neu5Ac in complex with RgNanH-GH33. a) DSTD histogram: positive
DSTDs (above the limit of +0.75) after aliphatic irradiation (0.6 ppm)
are shown in cyan, and negative DSTDs (below @0.75) after aromatic
irradiation (6.55 ppm) in magenta. b) DEEP-STD map of the ligand.
Cyan surfaces highlight ligand contacts with aliphatic side chains;
magenta surfaces show contacts with aromatic side chains. c) Crystal
structure of the complex (PDB ID: 4X4A).[9] Protons were added using
Schrodinger software.[14] Protein protons are colored as a function of
their NMR frequencies: those directly irradiated at 0.6 ppm (aliphatic
residues) in cyan and those directly irradiated at 6.55 ppm (aromatic
residues) in magenta (Table S1). Comparison of (b) and (c) highlights
the excellent match of the differential epitope map of the ligand with the
distribution of aliphatic and aromatic residues in the binding pocket.
Figure 1. A cartoon representing the two implementations of the
DEEP-STD NMR method. a) Different irradiation frequencies: ligand
protons receive larger saturation if the protein protons in their
proximity are “directly irradiated” instead of “relayed-NOE” saturated.
STD NMR is carried out with selective irradiation (d1) on protein
protons close to ligand proton B (i) and with selective irradiation (d2)
on protein protons close to ligand proton A (ii). The distinct binding
epitopes of the ligand are sketched in the free state. b) Different
solvent composition: ligand protons close to slowly exchanging
protein exchangeable protons receive less saturation if the latter are
exchanged to deuterium (in D2O) instead of a proton (in H2O). STD
NMR experiments are thus carried out in D2O (i) and H2O (ii).
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ones indicate increases when irradiating at 6.55 ppm (aro-
matic residues). The resulting differential epitope map is
shown in Figure 2b. The results show that different protons of
the ligand occupy distinct areas of the RgNanH-GH33
binding pocket lined by either aliphatic or aromatic residues.
The positive DSTD factors for CH3 and H3a suggest vicinity
to aliphatic side chains, whereas the negative DSTDs for H8,
H9 and H9’ suggest vicinity to aromatic protons.
The DEEP-STD NMR results are in excellent agreement
with the published crystal structure of the complex between
2,7-anhydro-sialic acid and RgNanH-GH33 (Figure 2c),[9]
where the ligand sits between aliphatic (I258, I338, and
V502) and opposite aromatic (Y667 and W698) patches. The
ligand protons CH3 and H3a point towards the aliphatic
residues, while H8, H9, and H9’ are projected towards the
aromatic side chains. Protons H3e, H4, H5, H6, and H7 sit in
between these two regions in agreement with their negligible
DSTD factors (Figure 2a). These results confirm that it is
possible to identify the nature of the ligand–receptor contacts
by means of differential protein irradiation.
We next studied the same protein–ligand system under
two different solvent conditions: D2O (exp1) or H2O (exp2).
The irradiation frequency was set at 0.6 ppm. In H2O, the
large pool of solvent protons acts as a magnetization sink,[15]
resulting in a global saturation lower than in D2O. For this
reason, we set exp1 in Equation 1 to be the experiment in
D2O. Thus, negative DSTD factors correspond to ligand
protons with reduced relative STDs in D2O, that is, adjacent
to slow exchanging polar residues in the bound state. We
recorded negative DSTD factors from differential D2O/H2O
experiments at protons H3a, H3e, H9, and H9’ (Figure 3a).
The resulting differential epitope map is shown in Figure 3b,
and portrays the areas of the ligand contacting polar residues.
Here again, the DEEP-STD NMR results were in line with
the crystal structure (Figure 3c), where the ligand protons
H3a, H3e, H9, and H9’ point towards a highly polar patch in
the RgNanH-GH33 binding pocket (R257, R276, R575, and
R637). This is in excellent agreement with the known slow
exchanging behavior of h protons of arginine residues in
H2O.
[8] Interestingly, the ligand methyl group showed a pos-
itive DSTD factor (Figure 3a), which is explained by the
presence of a fast exchanging hydroxy group (Y525) close to
the methyl groups of V502 (Figure 2c and Figure S1 in the
Supporting Information).[8]
Further, we applied this method to a complex of CTB,
a larger receptor (65 kDa), with 3NPG.[10] Remarkably, the
ligand contains an aromatic moiety, which precludes protein
irradiation in this spectral region. However, in DEEP-STD
NMR, it is possible to select other groups of protein protons
for irradiation, providing that they are in spectral regions
devoid of ligand signals. For CTB, we targeted protein
resonances at 2.25 ppm. We predicted the chemical shifts of
the protons of CTB within 4c of the ligand in the X-ray
structure, and the results indicated the E51 and Q56 protons
as the ones likely to be directly irradiated (Figure 4c, and
Table S1 in the Supporting Information).
Experiments conducted with differential frequencies
(2.25/0.60 ppm) resulted in positive DSTD values for protons
H4, H5, H6, and H6’ on the galactose, thus indicating an
increase in relative STDs when irradiating at 2.25 ppm
(Figure 4a). In contrast, negligible DSTD factors were
observed for H1, H2, H3, and the aromatic protons at the
opposite end of the molecule. The differential epitope map of
3NPG (Figure 4b) was found to be in perfect agreement with
the published crystal structure of the complex between 3NPG
and CTB (Figure 4c),[10] in which the galactose ring area of H4
to H6 is surrounded by the side chains of E51 and Q56. In
contrast, H1, H2, H3, and the aromatic carbon atoms point
away from those side chains in the binding pocket (Figure 4c).
Finally, we conducted DEEP-STD NMR experiments
with differential D2O/H2O conditions on the 3NPG–CTB
complex. The DSTDs of 3NPG were negligible, and no
differential epitope was obtained, thus indicating that chang-
ing solvent did not significantly affect the STD pattern
(Figure S4). This is in agreement with the lack of slowly
exchanging polar residues in the CTB binding pocket.[10] This
suggests that when no differential epitope is obtained after
a change from D2O to H2O, the protein binding pocket is
likely to lack slowly exchanging polar side chains (e.g., Arg).[8]
In summary, DEEP-STD NMR is a robust tool to get
information on the nature of the amino acids surrounding the
ligand in the binding site in order to assess the pharmaco-
phore of the protein. This information is inaccessible by
traditional STD NMR. Additionally, if the protein 3D
Figure 3. Differential Epitope Mapping (D2O/H2O) of 2,7-anhydro-
Neu5Ac in complex with RgNanH-GH33. a) DSTD histogram: protons
with an DSTD factor <@0.75 are shown in green. Protons H6 and H7
were excluded from the analysis due to their proximity to the water
peak and the use of solvent suppression. b) DEEP-STD map of the
ligand. Green surfaces indicate ligand contacts with protein side
chains carrying slowly exchanging protons. c) Crystal structure of the
complex (PDB ID: 4X4A).[9] Protons were added using Schrodinger
software.[14] The slowly exchangeable protons in the binding pocket are
depicted with green surfaces.
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structure is known, the method allows information to be
gained from STD NMR on the orientation of the ligand for
the first time. In comparison to the SOS-NMR method
proposed by Hajduk et al. to reveal ligand orientation,[16]
DEEP-STD NMR does not need selective protein deutera-
tion. We envisage that DEEP-STDNMR in combination with
classical STD NMR could become a popular approach to
characterize in depth the binding of weak ligands to protein
receptors. This is of great relevance to accelerate fragment-
based drug discovery efforts, an approach of increasing
importance in the biopharmaceutical industry for the devel-
opment of novel therapeutics.
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